We have studied the effect of age on wash in of isoflurane and halothane by comparing end-tidal (Pt) 
Administration of a volatile anaesthetic agent is facilitated by ability to predict the rate of washin (increase of partial pressures) of the agent following its introduction. The factors governing the rate of washin include alveolar ventilation, pulmonary function, cardiac output, the proportion of body mass composed of vessel rich, muscle and fat groups of tissues, and the blood/gas and tissue/blood partition coefficients of the agent [1] . The normal physiological process of ageing changes many of these: ventilation-perfusion (V/Q) inequality in the lungs increases, while diffusing capacity decreases [2] ; basal metabolic rate decreases, leading to decreased production of carbon dioxide and decreased minute ventilation [3] ; tissue/blood partition coefficients increase [4] ; and fat increases as a proportion of body mass [5] . These changes tend to decrease the rate of washin of volatile agents. Other ageing-induced physiological changes, however, tend to increase the rate of washin of volatile agents: the blood/gas partition coefficients of volatile agents decrease [6] and cardiovascular depression by volatile agents is greater in the elderly [7] [8] [9] .
Previously, we have compared washin of volatile agents in the young and elderly by measuring end-tidal concentrations of isoflurane and halothane in young and elderly normocapnic patients [10] . End-tidal isoflurane concentrations increased more slowly in the elderly; end-tidal halothane concentrations increased at the same rate in both age groups. However, two factors may modify interpretation of the results of this study. First, the elderly have a greater gradient between end-tidal (PE'CO.) an d arterial (Pa COj ) partial pressures of carbon dioxide [11] and ventilating both groups to the same PE' CO , may have caused relative underventilation of the elderly. This could explain slower washin of isoflurane in the elderly. Second, ageing increases ventilation-perfusion (V/Q) inequality [2] . End-tidal volatile agent partial pressures overestimate arterial partial pressures in the presence of V/Q inequality [12] and in the elderly may not accurately represent arterial or cerebral partial pressures. Arterial partial pressures, however, reflect cerebral partial pressures in the young [13, 14] and presumably in the elderly also.
To clarify the effects of ageing on washin of isoflurane and halothane, we measured arterial partial pressures of the agents in young and elderly patients undergoing ventilation to the same Pa co ,.
PATIENTS AND METHODS
Forty-one healthy (ASA grade I or II) patients were studied before elective orthopaedic surgery. All gave informed consent and the study was approved by the University Medical Research Ethics Committee. Patients with clinical evidence of respiratory or cardiovascular disease, and patients who were hypertensive (defined as a diastolic arterial pressure greater than 90 mm Hg) or obese (defined as a body weight greater than 120% of that predicted for age and height) were excluded. Twenty-one were young (18-32 yr) and 20 were elderly (63-82 yr); 20 subjects received isoflurane (10 young and 10 elderly), and the remainder received halothane. The two agents were not studied concurrently; all subjects who received isoflurane were studied before the subjects who received halothane. None of the subjects receiving halothane had been exposed recently to the agent.
Diazepam 0.15 mg kg" 1 was administered orally 1 h before anaesthesia. After insertion of a 22-gauge radial artery cannula, anaesthesia was induced with a dose of thiopentone sufficient to obtund the eyelash reflex and alfentanil 15 ug kg" 1 ; neuromuscular block was provided by pancuronium O.lmgkg"
1 . The lungs were ventilated manually with oxygen and the trachea was intubated with a tracheal tube which incorporated a gas sampling lumen (Portex). Intermittent positive pressure ventilation with oxygen was continued using a non-rebreathing system. Halothane or isoflurane was introduced in a concentration of 1 % (by vaporizer setting). Ventilation was adjusted to maintain PE' C O, The ECG, PE' COI and nasopharyngeal temperature were monitored continuously and arterial pressure was measured by automated oscillotonometer. Mean arterial pressure (MAP) was maintained greater than 60 mm Hg in all patients, if necessary by elevation of the legs. Two elderly patients receiving isoflurane and four receiving halothane required infusion of up to 300 ml of Dextran 70 to maintain MAP greater than this value. Pa COj was measured 10 and 20 min after introduction of the volatile agent using an automated blood-gas analyser (IL 1302), calibrated at 1-h intervals using standard carbon dioxide mixtures.
Gas from the distal trachea was sampled continuously via the gas sampling lumen of the tracheal tube and the end-tidal partial pressure of volatile agent was measured by infra-red analysis (Datex "Normac"). This monitor has a rapid response time and is accurate at concentrations used clinically [15] . Calibration was performed before each case using a known concentration of difluorochloromethane (CHC1F 2 ). The analog output of the vapour analyser was attached to a microcomputer (BBC "B") to calculate the inspired and end-tidal partial pressures of volatile agent [16] .
The accuracy of the infra-red vapour analyser was tested by comparing gas concentrations in the anaesthetic circuit measured by the analyser with those in samples drawn from the circuit and measured by gas chromatography. The infra-red analyser underestimated isoflurane and halothane partial pressures relative to gas chromatography. For isoflurane, the mean error was 6 % with 95 % "limits of agreement" (LA) for differences between the two methods of measurement (i.e. two standard deviations, as described by Bland and Altman [17] ) of ±8%. For halothane the mean error was 1 % with 95 % LA of ±20%. The data have not been corrected for these errors.
Samples of arterial blood were obtained for measurement of isoflurane or halothane partial pressures at 2, 5, 10, 15 and 20 min after introduction of the agent. After clearing the deadspace (0.7 ml) of the arterial cannula by discarding the initial 3 ml, 5-6 ml of arterial blood was obtained from the three-way tap on the cannula. Samples were drawn anaerobically into gas-tight, glass 10-ml syringes (Hamilton 1010 TLL). The syringes had a Teflon-coated plunger and were sealed with a Teflon-coated gas-tight stopcock (Mininert) until analysis. The deadspace of the syringe (0.2 ml) had been filled beforehand with heparin 1000 iu ml" 1 . Because of the low solubility of volatile agent in crystalloid solutions, the heparin solution was ignored in subsequent calculations. A sample of inspiratory gas was taken from the anaesthetic circuit 12 min after introduction of volatile agent.
Halothane and isoflurane partial pressures in blood and inspired gas were measured using a gas chromatograph (GC) (Perkin Elmer F33) equipped with a gas sampling valve (sampling loop 0.5 ml) and a flame ionization detector. The column was 60 cm long and 3 mm in diameter, made of borosilicate glass and packed with a polymer of styrene and ethylvinyl-benzene (Poropak Q). The carrier gas was oxygen-free nitrogen and the detector was supplied by hydrogen and air. Column temperature was 175 °C and detector temperature 225 °C. The retention time for isoflurane was 81 s, for halothane 119 s.
The GC was calibrated using four standards made by injecting measured amounts of liquid isoflurane from a microsyringe into gas-tight flasks of known volume. The volatile agent partial pressure in each standard was calculated and the chromatograph calibrated by plotting the peak heights of the standards against their known isoflurane or halothane partial pressures. The GC response to both agents was linear over a wide range of partial pressures. The coefficient of variation for measurement of volatile agent partial pressures in gas samples was 1.5 % for isoflurane and less than 1 % for halothane.
Analysis of blood samples for isoflurane or halothane partial pressure commenced within 1 h of drawing the samples, using the method described by Fink and Morikawa [18] . Excess blood was ejected from each syringe until exactly 5 ml remained in the syringe. Five millilitre of humidified air was drawn into the syringe and equilibrated with the blood in the syringe for 30 min on a rotating disc, at room temperature. Longer periods of equilibration produced no increase in partial pressures of volatile agent in the headspace gas above the blood. The headspace gas was injected into the GC and the volatile agent partial pressure in the gas (and thus blood) measured (P s ). The process was repeated: all air was removed from the syringe and a fresh 5 ml of humidified air drawn in. Equilibration of volatile agent partial pressures between blood and gas phases was again carried out for 30 min and the volatile agent partial pressure in the headspace gas (P 2 ) measured. The product of P x and the ratio P l : P 2 gave the partial pressure of halothane or isoflurane in the original blood sample at room temperature. This was converted to the partial pressure at body temperature by multiplying it by the ratio of saturated vapour pressure (SVP) at body temperature to the SVP at room temperature, in accordance with the theory given by Fink and Morikawa [18] (which gives results consistent with experimental data on the changes in blood solubility with temperature [19] ). The SVP at each temperature was calculated using the Antoine equation as described for isoflurane [20] and halothane [21] . Blood partial pressures of isoflurane were expressed as % of 1 standard atmosphere (% Atm).
The coefficient of variation for estimation of blood partial pressure was calculated on 10 samples drawn from a subject at a stable end-tidal concentration of each agent, and was found to be 2.4% for isoflurane, 5.6% for halothane.
The accuracy of measurement of blood partial pressures at room temperature was tested in blood samples of known blood partial pressure, prepared by equilibrating blood samples from a single volunteer with gas containing the volatile agent in a range of concentrations. All analyses were performed at room temperature. After equilibration so that partial pressures in the blood (Pb) and headspace gas were equal, the partial pressure of volatile agent in the headspace gas (Pb) was measured. Headspace gas was removed, the blood was equilibrated with air on two further occasions and partial pressures of volatile agent in the headspace gas (P x and P,) measured after each equilibration. The partial pressure of volatile agent in the original specimen was calculated as P 1 (P 1 /P i ) and compared with Pb, which had been measured directly. For isoflurane (n = 22), the calculated value for Pb underestimated the measured value by a mean 4 % (95 % LA ± 7 %), and for halothane (n = 10) by a mean 5 % (95 % LA ± 10 %). The data have not been corrected for these errors.
The blood/gas partition coefficient of each blood sample at 37 °C was calculated using the ratio P t : P 2 according to the theory of Fink and Morikawa [18] . (13) 87 (7) 88 (6) 89 (12) 88 (11) 94 (20) 91 (14) 89 (17) 88 ( (12) 83 (14) 89 (17) 89 (14) 90 (12) 80 (17) 78 (15) 75 (14) 74 (14) 73 ( (18) 91 (17) 87 (15) 85 (15) 84 (13) 105 (20) 104 (17) 101 ( End-tidal (PE') and arterial (Pa) partial pressures were expressed as proportions of the inspired partial pressure (Pi) before statistical analysis to correct for differences in Pi between groups. Statistical analysis was by two-factor (age group or agent, and time) repeated measures analysis of variance and unpaired t test, as appropriate; P < 0.05 was considered statistically significant.
RESULTS
Patient characteristics are shown in table I. For isoflurane, heart rate and arterial pressure did not differ significantly between young and elderly (table II) . For halothane, heart rates were less in the elderly than in the young, but there was no significant difference in mean arterial pressure. Body temperature did not differ between the groups. Pa COt did not differ significantly between young and elderly receiving either halothane or isoflurane, but was significantly less in subjects receiving halothane than in those given isoflurane (table II) . For halothane, PE'/PI was greater in the elderly for the first 10 min of administration; subsequently there was no difference between the age groups ( fig. 3) . Pa for halothane, however, increased more slowly in the elderly than in the young and Pa/Pi values were significantly less in the elderly after 10 min of halothane administration ( fig. 4) . Pi for halothane (measured by GC) was 0.96 (0.19)% Atm in the elderly and 0.85 (0.16)% Atm in the young.
Pa/Pi values were significantly greater for For isoflurane, the gradient between end-tidal and arterial partial pressures (PE'/PI) -(Pa/Pi) did not differ significantly between the young and elderly (table III) . For halothane, the (PE'/PI) -(Pa/Pi) gradient was greater in the elderly than in the young (table IV) . In young subjects the (PE'/PI) -(Pa/Pi) gradient did not differ significantly between isoflurane and halothane, but in elderly subjects the gradient was significantly greater for halothane than for isoflurane.
The blood/gas partition coefficient for isoflurane was significantly less in the elderly (mean 1.31, 95% confidence limits (CL) 1.21-1.41) than in the young (mean 1.48, 95% CL 1.36-1.59) (P < 0.05). The mean blood/gas partition coefficient for halothane was 2.82 (95 % CL 2.56-3.07) in the elderly and 3.03 (95% CL 2.74-3.32) in the young.
DISCUSSION
Washin of isoflurane occurred at the same rate in healthy elderly patients as in the young, despite the physiological changes associated with ageing. With both age groups at the same Pa^, PE' and Pa of isoflurane did not differ between young and elderly following introduction of the agent (figs 1, 2). Washin of halothane, however, occurred more slowly in the elderly, with Pa of halothane significantly less in the elderly than in the young (fig. 4) . The difference between the age groups was small, and unlikely to be of major clinical significance (especially as it is partly compensated for by the lower minimum alveolar concentration (MAC) for halothane in the elderly [22] ). Our study continued for only 20 min after introduction of the agents, and it is uncertain if Pa of halothane remained smaller in the elderly over a longer period.
Thus the physiological changes of ageing altered the washin of halothane but not of isoflurane. In the elderly, tissue/blood partition coefficients increase [4] , fat increases as a proportion of body mass [5] and minute ventilation decreases because of reduced metabolic rate [3] . These changes have a proportionately greater effect in slowing the washin of the more soluble agent, halothane [1] , and this may explain why ageing slowed the washin of halothane but not that of isoflurane.
Washin of isoflurane occurred more rapidly than washin of halothane in both young and elderly patients (figs 5, 6), despite slight relative underventilation in the isoflurane group (table  II) . This is consistent with the lower blood/gas partition coefficient of isoflurane and with results from previous studies [10, 23, 24] . The difference between the rates of uptake of the two agents is of sufficient magnitude to be clinically significant.
Our values for Pa/Pi and PE'/PI during washin of isoflurane were slightly less (10 %) and slightly greater, respectively, than those found by Cromwell and colleagues in awake volunteers spontaneously breathing subanaesthetic concentrations of isoflurane [23] . The differing results may be explained by increased V/Q inequality and intrapulmonary shunting in our patients because of anaesthesia and positive pressure ventilation [25] ; these pulmonary changes increase PE' and decrease Pa [12] . Similarly, our values for Pa/Pi and PE'/PI for halothane were, respectively, less and greater than those found by Munson and colleagues in conscious young volunteers spontaneously breathing subanaesthetic concentrations of halothane [24] . PE'/PI values found by Torri and co-workers in anaesthetized young patients were similar to ours [26] .
PE'/PI values for isoflurane and halothane in the current study are consistent with those in our earlier study when both young and elderly patients had the same PE' COI (4.7 kPa) [10] . In the previous study, PE'/PI values for isoflurane were smaller in the elderly than in the young, and for halothane there was no difference between age groups. In the current study, with the elderly at a smaller PE' COI than the young, PE'/PI values for isoflurane did not differ between young and elderly ( fig. 1 ) and PE'/PI values for halothane were, for a period, greater in the elderly. The effect of the slight increase in alveolar ventilation on PE'/PI in the elderly relative to the young demonstrates the importance of alveolar ventilation in determining the rate of washin of volatile agents.
For isoflurane, PE'-Pa gradients were small relative to Pa, and PE' was a useful guide to Pa in both young and elderly (table III) . For halothane, PE'-Pa in the young did not differ significantly from that found for isoflurane, but PE'-Pa in the elderly was significantly greater than in the young, and greater than in the elderly receiving isoflurane (table IV) . The gradient between PE' and Pa for volatile anaesthetic agents is proportional to the Pi-Pa gradient and is greater for agents of greater solubility [27] . The greater PE'-Pa gradient for halothane in the elderly than in the young may be explained by the greater Pi-Pa gradient and greater V/Q inequality in the elderly [2, 12, 27] .
The blood/gas partition coefficient for isoflurane was significantly less in the elderly and there was a similar trend for halothane (not statistically significant). Lower blood/gas partition coefficients in the elderly have been noted previously by Lerman and colleagues and may be a result of smaller plasma concentrations of albumin in this age group [6] . The blood/gas partition coefficients we found for isoflurane are similar to those found by Lerman's group, but our values for halothane are slightly greater than theirs (2.65 in the young, 2.41 in the elderly).
The smaller Pa COf values in the halothane group suggest a greater arterial to end-tidal gradient for carbon dioxide in subjects receiving halothane. However, because the halothane part of the study was carried out after isoflurane, it is impossible to say whether this reflected a real difference between the agents or a difference in the instruments for measuring PE' COf and Pa COj .
The elderly are a heterogenous population and our data apply only to healthy elderly patients. In elderly patients with coexisting disease, the likely effect of pathological processes on washin of isoflurane and halothane must be considered in conjunction with the data presented here.
